Trazodone For Insomnia: Guide To Potential Side Effects & Alternatives Released

Mission Connection Healthcare, a mental health provider that serves Virginia, Washington, and California, has released a guide on trazodone as a sleep aid.

-- The recently announced guide from Mission Connection Healthcare covers trazodone usage and side effects for individuals who are considering using the medication to treat insomnia. The guide also explores alternative treatment options for sleep issues, especially those caused by mental health conditions like depression and anxiety.

For more information, please visit https://missionconnectionhealthcare.com/mental-health/sleep-aids/trazodone/

According to a survey commissioned by the American Academy of Sleep Medicine, chronic insomnia affects a significant portion of the population, with an average of one in ten Americans being diagnosed with the condition in 2024. Insomnia and other sleeping issues have many causes, but these conditions are commonly treated with sleep aids - medications that induce drowsiness through various mechanisms.

Trazodone is a well-known antidepressant that is often prescribed as an off-label sleep aid for insomnia. Mission Connection’s guide says that the drug works by inhibiting the reabsorption of serotonin, prolonging its mood-regulating effects on the brain and its stabilizing effects on the sleep-wake cycle; it also blocks 5-HT2A receptors, H1 histamine receptors, and alpha-1 receptors, quelling alertness and calming the user.

While there are side effects associated with trazodone, Mission Connection’s team notes that they are mild and mostly include dizziness, headaches, and sustained sleepiness; however, overdosing can result in serotonin syndrome and cardiac arrhythmias, both of which can be life-threatening.

While trazodone can be used as a short-term solution for acute sleeping problems, insomnia caused by underlying issues, like mental health conditions, may not respond to medication. In these cases, the guide recommends nonmedical approaches like cognitive behavioral therapy, which is effective at identifying thoughts and behaviors that may be contributing to insomnia. These services are offered by Mission Connection through tailored outpatient therapy programs that include individual and group therapy sessions, the option for online appointments, experiential outings, guidance on mindfulness exercises, and other holistic treatments designed to promote long-term recovery.

The company’s guide adds that lifestyle adjustments, including good sleep hygiene, dietary changes, and physical activity, will promote better sleep quality and overall mental wellness, complementing the effect of sleep aids or removing reliance on them altogether. Individuals interested in this integrated approach are encouraged to speak to a psychiatrist for more information.

More details are available at https://missionconnectionhealthcare.com/

Contact Info:
Name: Nathan Di Tomaso
Email: Send Email
Organization: Mission Connection
Address: 30310 Rancho Viejo Rd. , San Juan Capistrano, California 92675, United States
Website: https://missionconnectionhealthcare.com/

Source: PressCable

Release ID: 89178860

In the event of any inaccuracies, problems, or queries arising from the content shared in this press release, we encourage you to notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team will be readily available to respond and take swift action within 8 hours to rectify any identified issues or assist with removal requests. Ensuring the provision of high-quality and precise information is paramount to us.

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.91
+0.37 (0.17%)
AAPL  274.84
+0.73 (0.27%)
AMD  208.97
+1.39 (0.67%)
BAC  55.02
-0.30 (-0.55%)
GOOG  307.26
-2.06 (-0.67%)
META  660.39
+12.88 (1.99%)
MSFT  476.86
+2.04 (0.43%)
NVDA  177.35
+1.06 (0.60%)
ORCL  189.48
+4.56 (2.47%)
TSLA  489.20
+13.89 (2.92%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.